PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Up 322.1% in February

PMGC Holdings Inc. (NASDAQ:ELAB) was the recipient of a large increase in short interest during the month of February. As of February 13th, there was short interest totaling 129,521 shares, an increase of 322.1% from the January 29th total of 30,685 shares. Approximately 25.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,241,514 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 4,241,514 shares, the days-to-cover ratio is currently 0.0 days. Approximately 25.7% of the shares of the stock are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, PMGC presently has a consensus rating of “Sell”.

PMGC Price Performance

Shares of ELAB stock opened at $1.19 on Friday. PMGC has a 12-month low of $1.02 and a 12-month high of $129.36. The business has a 50 day simple moving average of $3.53 and a 200 day simple moving average of $15.56. The firm has a market capitalization of $3.87 million, a price-to-earnings ratio of -0.02 and a beta of 0.70.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.